ArticlePharmaceuticals (Basel, Switzerland)2023

S-72, a Novel Orally Available Tubulin Inhibitor, Overcomes Paclitaxel Resistance via Inactivation of the STING Pathway in Breast Cancer.

Zhenyan Hou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.